Emory 3D Symposium 2023: Accelerating Drug Discovery and Development

The Department of Pharmacology and Chemical Biology and the Winship Cancer Institute hosted the Emory 3D Symposium: Accelerating Drug Discovery & Development, April 13, 2023.

Opening Remarks and Introduction

Opening Remarks by Ravi Thadhani, EVP of Health Affairs at Emory

Opening Remarks by Kim Kerstann, Chief Administrative Officer of Winship Cancer Institute

Keynote address by Shaomeng Wang, Director, Michigan Center for Therapeutic Innovation, University of Michigan.

Introduction by Haian Fu, Chair, Pharmacology & Chemical Biology

Session 1: Emory’s Success in Drug Discovery and Development

Chair: Stefan Sarafianos, Co-Director, Center for ViroScience and Cure

Speakers:
Dennis Liotta, Chair, Advisory Committees of DRIVE and EIDD, Emory University
George Painter, CEO of DRIVE, Executive Director Of EIDD, Emory University
Wendy Painter, Chief Medical Officer, Ridgeback Biotherapeutics

Stefan Sarafinos

George Painter

Wendy Painter

Session 2: Innovations in drug discovery and development for cancer therapeutics

Chair: Sumin Kang, Associate Professor and Division Director, Hematology and Medical Oncology

Speakers:
Charlie Garnett-Benson, Senior Scientific Director, Translational Medicine, Bristol Myers Squibb
Donna Huryn, PI, University of Pittsburgh Chemical Diversity Center
Ravi Iyengar, Director, Mount Sinai Institute for Systems Biomedicine